312 related articles for article (PubMed ID: 31524038)
1. Modulators of platelet function in aging.
Iyer KS; Dayal S
Platelets; 2020 May; 31(4):474-482. PubMed ID: 31524038
[TBL] [Abstract][Full Text] [Related]
2. Platelet dysfunction in vascular pathologies and how can it be treated.
Alexandru N; Popov D; Georgescu A
Thromb Res; 2012 Feb; 129(2):116-26. PubMed ID: 22035630
[TBL] [Abstract][Full Text] [Related]
3. Platelet biology and functions: new concepts and clinical perspectives.
van der Meijden PEJ; Heemskerk JWM
Nat Rev Cardiol; 2019 Mar; 16(3):166-179. PubMed ID: 30429532
[TBL] [Abstract][Full Text] [Related]
4. Platelet Function in Cardiovascular Disease: Activation of Molecules and Activation by Molecules.
Khodadi E
Cardiovasc Toxicol; 2020 Feb; 20(1):1-10. PubMed ID: 31784932
[TBL] [Abstract][Full Text] [Related]
5. Role of oxidative stress on platelet hyperreactivity during aging.
Fuentes E; Palomo I
Life Sci; 2016 Mar; 148():17-23. PubMed ID: 26872977
[TBL] [Abstract][Full Text] [Related]
6. Platelets, inflammation and anti-inflammatory effects of antiplatelet drugs in ACS and CAD.
Müller KA; Chatterjee M; Rath D; Geisler T
Thromb Haemost; 2015 Aug; 114(3):498-518. PubMed ID: 26224127
[TBL] [Abstract][Full Text] [Related]
7. Role of Platelet Activation and Oxidative Stress in the Evolution of Myocardial Infarction.
Fuentes E; Moore-Carrasco R; de Andrade Paes AM; Trostchansky A
J Cardiovasc Pharmacol Ther; 2019 Nov; 24(6):509-520. PubMed ID: 31280622
[TBL] [Abstract][Full Text] [Related]
8. Age associated non-linear regulation of redox homeostasis in the anucleate platelet: Implications for CVD risk patients.
Jain K; Tyagi T; Patell K; Xie Y; Kadado AJ; Lee SH; Yarovinsky T; Du J; Hwang J; Martin KA; Testani J; Ionescu CN; Hwa J
EBioMedicine; 2019 Jun; 44():28-40. PubMed ID: 31130473
[TBL] [Abstract][Full Text] [Related]
9. [Platelet inhibition and activation. Mechanisms and clinical implications].
Alberio L; Clemetson KJ
Herz; 2005 May; 30(3):176-80. PubMed ID: 15902367
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis.
Jennings LK
Thromb Haemost; 2009 Aug; 102(2):248-57. PubMed ID: 19652875
[TBL] [Abstract][Full Text] [Related]
11. Platelet hyperactivity in type 2 diabetes: role of antiplatelet agents.
Natarajan A; Zaman AG; Marshall SM
Diab Vasc Dis Res; 2008 Jun; 5(2):138-44. PubMed ID: 18537103
[TBL] [Abstract][Full Text] [Related]
12. Platelet activation in essential hypertension: implications for antiplatelet treatment.
Gkaliagkousi E; Passacquale G; Douma S; Zamboulis C; Ferro A
Am J Hypertens; 2010 Mar; 23(3):229-36. PubMed ID: 20094035
[TBL] [Abstract][Full Text] [Related]
13. Platelet dysfunction in central obesity.
Anfossi G; Russo I; Trovati M
Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):440-9. PubMed ID: 19346117
[TBL] [Abstract][Full Text] [Related]
14. The relationship of platelet reactivity to the occurrence of post-stenting ischemic events: emergence of a new cardiovascular risk factor.
Gurbel PA
Rev Cardiovasc Med; 2006; 7 Suppl 4():S20-8. PubMed ID: 17224887
[TBL] [Abstract][Full Text] [Related]
15. Pharmacology of platelet activation-inhibitory drugs.
Rao GH; Rao AT
Indian J Physiol Pharmacol; 1994 Apr; 38(2):69-84. PubMed ID: 8063366
[TBL] [Abstract][Full Text] [Related]
16. Platelets in rheumatic diseases: friend or foe?
Gasparyan AY; Ayvazyan L; Pretorius E; Kitas GD
Curr Pharm Des; 2014; 20(4):552-66. PubMed ID: 23565634
[TBL] [Abstract][Full Text] [Related]
17. Altered functions of platelets during aging.
Montenont E; Rondina MT; Campbell RA
Curr Opin Hematol; 2019 Sep; 26(5):336-342. PubMed ID: 31348047
[TBL] [Abstract][Full Text] [Related]
18. Functional Relevance of the Anaphylatoxin Receptor C3aR for Platelet Function and Arterial Thrombus Formation Marks an Intersection Point Between Innate Immunity and Thrombosis.
Sauter RJ; Sauter M; Reis ES; Emschermann FN; Nording H; Ebenhöch S; Kraft P; Münzer P; Mauler M; Rheinlaender J; Madlung J; Edlich F; Schäffer TE; Meuth SG; Duerschmied D; Geisler T; Borst O; Gawaz M; Kleinschnitz C; Lambris JD; Langer HF
Circulation; 2018 Oct; 138(16):1720-1735. PubMed ID: 29802205
[TBL] [Abstract][Full Text] [Related]
19. Novel endogenous negative modulators of platelet function as potential anti-thrombotic targets.
Li YJ; Zhu HX; Zhang D; Li HC; Ma P; Huang LY
Eur Rev Med Pharmacol Sci; 2017 Jul; 21(13):3146-3158. PubMed ID: 28742189
[TBL] [Abstract][Full Text] [Related]
20. Platelets and vascular risk: an option for treatment.
Jagroop IA; Kakafika AI; Mikhailidis DP
Curr Pharm Des; 2007; 13(16):1669-83. PubMed ID: 17584097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
